XRCC1 Arg194Trp and Arg399Gln polymorphisms and risk of extrahepatic cholangiocarcinoma: a hospital-based case-control study in China

被引:0
作者
Gong, Yuanfeng [1 ]
Qi, Ming [2 ]
Chen, Jun [1 ]
Fang, Runya [1 ]
Mai, Cong [1 ]
Chen, Tiejun [1 ]
Tang, Hui [1 ]
Tang, Yunqiang [1 ]
机构
[1] Guangzhou Med Univ, Affiliated Canc Hosp, Dept Hepatobiliary Surg, 78 Hengzhigang Rd, Guangzhou 510095, Guangdong, Peoples R China
[2] Shandong Univ, Shandong Prov Hosp, Dept Breast & Thyroid Surg, Jinan 250021, Peoples R China
来源
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE | 2015年 / 8卷 / 10期
关键词
XRCC1; polymorphism; cholangiocarcinoma; risk; susceptibility; DNA-REPAIR GENES; CANCER-RISK; ARG280HIS POLYMORPHISMS; SUSCEPTIBILITY; ASSOCIATION; EPIDEMIOLOGY; METAANALYSIS;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Extrahepatic cholangiocarcinoma (ECCA) is a rare but devastating malignancy. Up to 90% of patients presenting with ECCA have no identifiable risk factors. The base excision repair (BER) pathway has a principal role in the repair of mutations caused by oxidized or reduced bases. The XRCC1 is one of the key proteins in the BER pathway. In this study, we investigated the influence of XRCC1 Arg194Trp and Arg399Gln polymorphisms on ECCA incidence. Methods: The study included 189 ECCA patients and 216 controls. Genotypes were detected by polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP) method. Results: For codon 194, the genotype frequencies of C/C, T/C and T/T were 51.3, 43.4 and 5.3%, respectively, in the ECCA cases compared with 54.2, 38.9 and 6.9%, respectively, in the controls. No statistically significant differences were observed in the genotype frequencies of codon 194 between the two groups compared to the control (TC, OR: 0.85, 95% CI: 0.57-1.28, TT, OR: 1.24, 95% CI: 0.54-2.89, TC+TT, OR: 0.89, 95% CI: 0.60-1.32). For codon 399, the genotype frequencies of G/G, G/A and A/A were 54.0, 37.0 and 9.0%, respectively, in the ECCA cases compared with 56.1, 39.8 and 4.1%, respectively, in the controls. No statistically significant differences were observed in the genotype frequencies codon 399 between the two groups compared to the control (GA, OR: 1.04, 95% CI: 0.69-1.56, AA, OR: 0.45, 95% CI: 0.19-1.04, GA+AA, OR: 0.92, 95% CI: 0.62-1.36). Meanwhile, no statistically significant differences were found in the haplotype and risk of developing ECCA compared to the control (CA, OR: 0.83, 95% CI: 0.49-1.39, TG, OR: 0.96, 95% CI: 0.58-1.60, TA, OR: 0.83, 95% CI: 0.38-1.82). Conclusion: The present study suggested that Arg194Trp and Arg399Gln polymorphism in the DNA repair gene XRCC1 was not statistically associated with risk of ECCA. It would be necessary to confirm these findings in a large sample size and multiethnic population study in future.
引用
收藏
页码:19339 / 19345
页数:7
相关论文
共 27 条
  • [1] Beyond genome-wide association studies: genetic heterogeneity and individual predisposition to cancer
    Galvan, Antonella
    Ioannidis, John P. A.
    Dragani, Tommaso A.
    [J]. TRENDS IN GENETICS, 2010, 26 (03) : 132 - 141
  • [2] Cholangiocarcinoma: Update and future perspectives
    Gatto, Manuela
    Bragazzi, Maria Consiglia
    Semeraro, Rossella
    Napoli, Cristina
    Gentile, Raffaele
    Torrice, Alessia
    Gaudio, Eugenio
    Alvaro, Domenico
    [J]. DIGESTIVE AND LIVER DISEASE, 2010, 42 (04) : 253 - 260
  • [3] RETRACTED: Lack of association of XRCC1 rs1799782 genetic polymorphism with risk of pancreatic cancer: a meta-analysis (Retracted article. See April, 2017)
    He, Gengsheng
    Chen, Guodong
    Chen, Wenqi
    Zhang, Wei
    Cao, Jinmin
    Ye, Qifa
    [J]. TUMOR BIOLOGY, 2014, 35 (05) : 4545 - 4550
  • [4] Höblinger A, 2008, CURR OPIN GASTROEN, V24, P363, DOI 10.1097/MOG.0b013e3282f79b32
  • [5] Selected base excision repair gene polymorphisms and susceptibility to biliary tract cancer and biliary stones: a population-based case-control study in China
    Huang, Wen-Yi
    Gao, Yu-Tang
    Rashid, Asif
    Sakoda, Lori C.
    Deng, Jie
    Shen, Ming-Chang
    Wang, Bin-Sheng
    Han, Tian-Quan
    Zhang, Bai-He
    Chen, Bingshu E.
    Rosenberg, Philip S.
    Chanock, Stephen J.
    Hsing, Ann W.
    [J]. CARCINOGENESIS, 2008, 29 (01) : 100 - 105
  • [6] XRCC1 Arg399Gln, Arg194Trp and Arg280His polymorphisms in breast cancer risk: a meta-analysis
    Huang, Yongsheng
    Li, Linguo
    Yu, Long
    [J]. MUTAGENESIS, 2009, 24 (04) : 331 - 339
  • [7] Epigenetic alterations associated with cholangiocarcinoma (Review)
    Isomoto, Hajime
    [J]. ONCOLOGY REPORTS, 2009, 22 (02) : 227 - 232
  • [8] Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma
    Jarnagin, WR
    Fong, Y
    DeMatteo, RP
    Gonen, M
    Burke, EC
    Bodniewicz, J
    Youssef, M
    Klimstra, D
    Blumgart, LH
    [J]. ANNALS OF SURGERY, 2001, 234 (04) : 507 - 517
  • [9] Jiang Jun, 2009, V471, P305, DOI 10.1007/978-1-59745-416-2_16
  • [10] Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma
    Khan, S. A.
    Toledano, M. B.
    Taylor-Robinson, S. D.
    [J]. HPB, 2008, 10 (02) : 77 - 82